Market Overview

The Kidney Cancer market is predicted to develop at a compound annual growth rate (CAGR) of 4.9% from 2025 to 2035, when it is projected to reach USD 10.95 Billion, based on an average growth pattern. The market is estimated to reach a value of USD 7.35 Billion in 2025.

SOURCE: We Market Research

Renal cell carcinoma, also referred to as kidney cancer, is a type of cancer that starts in the kidneys, which are essential organs in charge of eliminating waste materials from the body through the generation of urine and filtering blood. The lining of the kidneys' tiny tubes, or tubules, is where kidney cancer usually starts. Kidney cancer's precise etiology is frequently unknown, while risk factors like smoking, obesity, high blood pressure, and family history may make the disease more likely to occur. Kidney cancer can cause fever, exhaustion, weight loss, back pain, stomach pain, and blood in the urine. Treatment options vary based on the disease's stage and extent and may include immunotherapy, surgery, targeted therapy, and occasionally radiation therapy. Kidney cancer management and surveillance depend on routine medical check-ups.

Increasing incidence of the disease, improvements in imaging and biomarker technologies, and cutting-edge therapeutic options like targeted and immunotherapies are driving the global kidney cancer market. Strong research and development initiatives aimed at comprehending the biology of kidney cancer and creating novel treatments propel the market's expansion. The growth of the market is facilitated by initiatives in healthcare, government regulations that are supportive, and increasing patient awareness. Technological developments in surgery and medical equipment also lead to better treatment results. This dynamic ecosystem is the result of a global effort to solve kidney cancer's difficulties and improve patient treatment. 

Market Scope

Kidney Cancer Industry: Dynamics & Restrains 

Kidney Cancer Market Opportunity:

Our marketing platform offers a comprehensive dashboard that provides clients with valuable insights into market trends over the years. Included below is a sample image of our dashboard, and specific PDF logins will be furnished to grant access to this insightful tool.

Kidney Cancer Market Segmentation

Market- By Type Analysis

By Type, the Kidney Cancer Market is Categories into renal cell cancer, transitional cell cancer, and Wilms tumor. The renal cell cancer segment accounts for the largest share of around 82% in 2024.

The renal cell carcinoma (RCC) subsegment holds a dominating position in the worldwide kidney cancer market, primarily due to the increased demand for expensive and novel medications created by breakthroughs in RCC diagnosis and treatment.

The following segments are part of an in-depth analysis of the global Kidney Cancer market:

Kidney Cancer Industry: Regional Analysis

North America Market Forecast

North America dominate the Kidney Cancer Market with the highest revenue generating market with share of more than 49%. North America holds a significant market share for kidney cancer due to factors such as a highly developed healthcare system, a high incidence of kidney cancer, and increased awareness about early detection and treatment options. Novel treatments are released as a consequence of extensive research and development efforts in the field. Benefitous reimbursement policies and increased investment on oncology research are further factors propelling this market's growth in North America.

Europe Market Statistics

Europe is now a major player in the renal cancer market due to a growing elderly population and a rise in kidney cancer cases. The presence of eminent research institutions and pharmaceutical companies fosters the development of novel therapeutic options. In addition, government initiatives that raise cancer awareness and facilitate access to treatment are crucial for the expansion of the industry across Europe.

Asia Pacific Market Forecasts

Asia Pacific is expected to be the fastest-growing regional segment of the Kidney Cancer market during the forecast period. The kidney cancer market in the Asia Pacific area is growing quickly, mostly as a result of better healthcare infrastructure, rising disposable income, and rising healthcare costs. Another factor boosting the industry is growing consumer knowledge of early diagnosis and treatment options. Furthermore, market participants have ample opportunity to increase their market share through successful market penetration tactics because to the sizeable patient pool in nations such as China and India.

Key Market Players 

         The Kidney Cancer Market is dominated by a few large companies, such as

·         Merck

·         Novartis

·         AstraZeneca

·         Bristol-Myers Squibb

·         Pfizer

·         Roche

·         Amgen

·         Argos Therapeutics

·         Aveo Pharmaceuticals

·         Bayer

·         Exelixis

·         Incyte

·         Allergan

·         Other

1.      Global Kidney Cancer Market Introduction and Market Overview

1.1.    Objectives of the Study

1.2.    Global Kidney Cancer Market Scope and Market Estimation

1.2.1. Global Kidney Cancer Overall Market Size, Revenue (US$ Mn), Market CAGR (%), Market forecast (2023 - 2034)

1.2.2. Global Kidney Cancer Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2019 - 2034

1.3.    Market Segmentation

1.3.1. Component of Global Kidney Cancer Market

1.3.2. Technology of Global Kidney Cancer Market

1.3.3. End-user of Global Kidney Cancer Market

1.3.4. Region of Global Kidney Cancer Market

2.      Executive Summary

2.1.    Global Kidney Cancer Market Industry Trends under COVID-19 Outbreak

2.1.1. Global COVID-19 Status Overview

2.1.2. Influence of COVID-19 Outbreak on Global Kidney Cancer Market Industry Development

2.2.    Market Dynamics

2.2.1. Drivers

2.2.2. Limitations

2.2.3. Opportunities

2.2.4. Impact Analysis of Drivers and Restraints

2.3.    Pricing Trends Analysis & Average Selling Prices (ASPs)

2.4.    Key Mergers & Acquisitions, Expansions, JVs, Funding / VCs, etc.

2.5.    Porter’s Five Forces Analysis

2.5.1. Bargaining Power of Suppliers

2.5.2. Bargaining Power of Buyers

2.5.3. Threat of Substitutes

2.5.4. Threat of New Entrants

2.5.5. Competitive Rivalry

2.6.    Value Chain / Ecosystem Analysis

2.7.    Russia-Ukraine War Impacts Analysis

2.8.    Economic Downturn Analysis

2.9.      Market Investment Opportunity Analysis (Top Investment Pockets), By Segments & By Region

3.      Global Kidney Cancer Market Estimates & Historical Trend Analysis (2019 - 2023)

4.      Global Kidney Cancer Market Estimates & Forecast Trend Analysis, by TYPE

4.1.    Global Kidney Cancer Market Revenue (US$ Mn) Estimates and Forecasts, by TYPE, 2019 to 2034

4.1.1. Renal cell cancer

4.1.2. Transitional cell cancer

4.1.3. Wilms tumor

5.      Global Kidney Cancer Market Estimates & Forecast Trend Analysis, by Treatment Modalities

5.1.    Global Kidney Cancer Market Revenue (US$ Mn) Estimates and Forecasts, by Treatment Modalities, 2019 to 2034

5.1.1. Type of surgery

5.1.2. Targeted therapy

5.1.3. Immunotherapy

5.1.4. Radiation therapy

5.1.5. Emerging therapies

6.      Global Kidney Cancer Market Estimates & Forecast Trend Analysis, by End-user

6.1.    Global Kidney Cancer Market Revenue (US$ Mn) Estimates and Forecasts, by End-user, 2019 to 2034

6.1.1. Hospitals

6.1.2. Homecare

6.1.3. Specialty Clinics

6.1.4. Others

7.      Global Kidney Cancer Market Estimates & Forecast Trend Analysis, by Region

7.1.    Global Kidney Cancer Market Revenue (US$ Mn) Estimates and Forecasts, by Region, 2019 to 2034

7.1.1. North America

7.1.2. Europe

7.1.3. Asia Pacific

7.1.4. Middle East & Africa

7.1.5. South America

8.      North America Kidney Cancer Market: Estimates & Forecast Trend Analysis

8.1.    North America Kidney Cancer Market Assessments & Key Findings

8.1.1. North America Kidney Cancer Market Introduction

8.1.2. North America Kidney Cancer Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

8.1.2.1.   By TYPE

8.1.2.2.   By Treatment Modalities

8.1.2.3.   By End-user

8.1.2.4.   By Country

8.1.2.4.1.     The U.S.

8.1.2.4.2.     Canada

8.1.2.4.3.     Mexico

9.      Europe Kidney Cancer Market: Estimates & Forecast Trend Analysis

9.1.    Europe Kidney Cancer Market Assessments & Key Findings

9.1.1. Europe Kidney Cancer Market Introduction

9.1.2. Europe Kidney Cancer Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

9.1.2.1.   By TYPE

9.1.2.2.   By Treatment Modalities

9.1.2.3.   By End-user

9.1.2.4.        By Country

9.1.2.4.1.     Germany

9.1.2.4.2.     U.K.

9.1.2.4.3.     France

9.1.2.4.4.     Italy

9.1.2.4.5.     Spain

9.1.2.4.6.     Russia

9.1.2.4.7.     Rest of Europe

10.  Asia Pacific Kidney Cancer Market: Estimates & Forecast Trend Analysis

10.1.  Asia Pacific Market Assessments & Key Findings

10.1.1.   Asia Pacific Kidney Cancer Market Introduction

10.1.2.   Asia Pacific Kidney Cancer Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

10.1.2.1.    By TYPE

10.1.2.2.    By Treatment Modalities

10.1.2.3.    By End-user

10.1.2.4.    By Country

10.1.2.4.1. China

10.1.2.4.2. Japan

10.1.2.4.3. India

10.1.2.4.4. Australia

10.1.2.4.5. South Korea

10.1.2.4.6. ASEAN

10.1.2.4.7. Rest of Asia Pacific

11.  Middle East & Africa Kidney Cancer Market: Estimates & Forecast Trend Analysis

11.1.  Middle East & Africa Market Assessments & Key Findings

11.1.1.   Middle East & Africa Kidney Cancer Market Introduction

11.1.2.   Middle East & Africa Kidney Cancer Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

11.1.2.1.    By TYPE

11.1.2.2.    By Treatment Modalities

11.1.2.3.    By End-user

11.1.2.4.    By Country

11.1.2.4.1. U.A.E.

11.1.2.4.2. Saudi Arabia

11.1.2.4.3. Egypt

11.1.2.4.4. South Africa

11.1.2.4.5. Rest of Middle East & Africa

12.  South America Kidney Cancer Market: Estimates & Forecast Trend Analysis

12.1.  South America Market Assessments & Key Findings

12.1.1.   South America Kidney Cancer Market Introduction

12.1.2.   South America Kidney Cancer Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

12.1.2.1.    By TYPE

12.1.2.2.    By Treatment Modalities

12.1.2.3.    By End-user

12.1.2.4.    By Country

12.1.2.4.1. Brazil

12.1.2.4.2. Argentina

12.1.2.4.3. Colombia

12.1.2.4.4. Rest of South America

13.  Competition Landscape

13.1.  Global Kidney Cancer Market Competition Matrix & Benchmarking, by Leading Players / Innovators / Emerging Players / New Entrants

13.2.  Global Kidney Cancer Market Competition White Space Analysis, By End-user

13.3.  Global Kidney Cancer Market Competition Heat Map Analysis, By End-user

13.4.  Global Kidney Cancer Market Concentration & Company Market Shares (%) Analysis, 2022

14.  Company Profiles

14.1.                     Merck

14.1.1.   Company Overview & Key Stats

14.1.2.   Financial Performance & KPIs

14.1.3.   Product Portfolio

14.1.4.   Business Strategy & Recent Developments

* Similar details would be provided for all the players mentioned below 

14.2.      Novartis

14.3.      AstraZeneca

14.4.      Bristol-Myers Squibb

14.5.      Pfizer

14.6.      Roche

14.7.      Amgen

14.8.      Argos Therapeutics

14.9.      Aveo Pharmaceuticals

14.10.  Bayer

14.11.  Exelixis

14.12.  Incyte

14.13.  Allergan

14.14.  Others

15.  Research Methodology

15.1.  External Transportations / Databases

15.2.  Internal Proprietary Database

15.3.  Primary Research

15.4.  Secondary Research

15.5.  Assumptions

15.6.  Limitations

15.7.  Report FAQs

16.  Research Findings & Conclusion